Abstract
THE lack of cellular specificity1 of the prostaglandins creates potential hazards in their use as therapeutic agents: we describe one associated with PGE2, and the reversal of the effect with aspirin.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
We are sorry, but there is no personal subscription option available for your country.
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bergstrom, S., Carlson, L. A., and Weeks, J. R., Pharmacol. Rev., 20, 1 (1968).
Kloeze, J., in Prostaglandins (edit. by. Bergstrom, S., and Samuelsson, B.), 241 (Almqvist and Wiksell, Stockholm, 1967).
Hissen, W., Fleming, J. S., Bierwagen, M. E., and Pindell, M. H., Microvasc. Res., 1, 374 (1969).
Hornstra, G., Europ. J. Pharmacol., 15, 343 (1971).
Marquis, N. R., Vigdahl, R. L., and Tavormina, P. A., Biochem. Biophys. Res. Commun., 36, 965 (1969).
Robison, G. A., Arnold, A., and Hartman, R. C., Pharmacol. Res. Commun., 1, 325 (1969).
Shio, H., Plasse, A. M., and Ramwell, P. W., Microvasc. Res., 2, 294 (1970).
Born, G. V. R., Nature, 194, 927 (1962).
Corey, E. J., Schaaf, T. K., Huber, W., Koelliker, U., and Weinshenker, N. M., J. Amer. Chem. Soc., 92, 397 (1970).
McMillan, D. C., Nature, 211, 140 (1966).
Zucker, M. B., and Peterson, J., Proc. Soc. Exp. Biol. Med., 127, 547 (1968).
Sutor, A. H., Bowie, E. J. W., and Owen, C. A., Mayo Clin. Proc., 46, 178 (1971).
van Creveld, S., and Pascha, C. N., Nature, 218, 361 (1968).
Shio, H., and Ramwell, P. W., in Prostaglandins in Cellular Biology and the Inflammatory Process (edit. by Ramwell, P. W, and Pharriss, B. B. (Plenum, New York, in the press).
Abdulla, Y. H., and McFarlane, E., Biochem. Pharmacol., 20, 1726 (1971).
Smith, J. B., and Willis, A. L., Brit. J. Pharmacol., 40, 545P (1970).
Smith, J. B., and Willis, A. L., Nature New Biology, 231, 235 (1971).
Willis, A. L., J. Pharm. Pharmacol., 21, 126 (1969).
Marcus, A. J., Ullman, H. L., and Safier, L. B., J. Lipid Res., 10, 108 (1969).
Embrey, M., Ann. NY Acad. Sci., 180, 518 (1971).
Mustard, J. F., and Packham, M. A., in Inflammation, Immunity and Hypersensitivity (edit. by Movat, H. Z.), 527 (Harper and Row, New York, 1971).
Danta, G., Thromb. Diath. Haemorrh., 23, 159 (1970).
Zahavi, J., and Dreyfuss, F., Thromb. Diath. Haemorrh., 21, 76 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
SHIO, H., RAMWELL, P. Effect of Prostaglandin E2 and Aspirin on the Secondary Aggregation of Human Platelets. Nature New Biology 236, 45–46 (1972). https://doi.org/10.1038/newbio236045a0
Received:
Issue Date:
DOI: https://doi.org/10.1038/newbio236045a0
This article is cited by
-
Thrombocytopenia provoked by carrageenan in rabbits and the inhibitory effect of lysozyme
Agents and Actions (1982)
-
Ocular neovascularization
International Ophthalmology (1980)
-
Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid
Agents and Actions (1975)
-
Effects of prostaglandin E2 on human platelet adenyl cyclase and aggregation
Nature (1974)